Showing results (291-300 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trialNicola M Neary, Caroline J Small, Alison M Wren, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppressionR Charles Nichols, Christopher G Morris, Bradford S Hoppe, et al.
The Journal of Heredity|October 2, 2013
Population differentiation of 2 forms of Bryde's whales in the Indian and Pacific OceansFrancine Kershaw, Matthew S Leslie, Tim Collins, et al.
Breast Cancer Research and Treatment|January 20, 2024
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation studyR Charles Coombes, Christina Angelou, Zamzam Al-Khalili, et al.
The Journal of Biological Chemistry|October 7, 2003
FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell linesAndrew Sunters, Silvia Fernández de Mattos, Marie Stahl, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicityR Charles Nichols, Thomas J George, Robert A Zaiden, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018William F Regine, Frederick A Schmitt, Charles B Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxelKaiyumars B Contractor, Laura M Kenny, Justin Stebbing, et al.
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
British Journal of Cancer|September 10, 2022
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancerDaniel Fernandez-Garcia, Georgios Nteliopoulos, Robert K Hastings, et al.
Pageof 41